BMY vs JAGX · P/E 17, rev $24.46B vs rev $1.2M
Bristol-Myers Squibb Company (BMY) versus Jaguar Animal Health Inc (JAGX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. JAGX currently screens at market cap $1.7M.
Not investment advice. Open the BMY and JAGX stock pages for the full models.
Not investment advice.